Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies.

Lundberg, Kristina Ihrmark; Treis, Diana; Johnsen, John Inge

Lundberg, Kristina Ihrmark; Treis, Diana; Johnsen, John Inge.

Afiliación

Lundberg KI; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, 17177, Stockholm, Sweden.
Treis D; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, 17177, Stockholm, Sweden.
Johnsen JI; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, 17177, Stockholm, Sweden. john.inge.johnsen@ki.se.

Curr Oncol Rep ; 24(8): 1053-1062, 2022 08.

Article en En | MEDLINE | ID: mdl-35362827

Asunto(s)

Neuroblastoma; Humanos; Neuroblastoma/genética; Neuroblastoma/terapia; Microambiente Tumoral

Palabras clave

ALK inhibitors; Differentiation therapy; Tumor heterogeneity; Tumor microenvironment; Tumor plasticity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuroblastoma Límite: Humans Idioma: En Revista: Curr Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google